drugset / Trial / NCT00783081
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cilostazol | Small molecule | 100 mg | — |
| Subject | K-134 | Small molecule | 25 mg | — |
| Subject | K-134 | Small molecule | 50 mg | — |
| Subject | K-134 | Small molecule | 100 mg | — |